STOCK TITAN

SEALSQ VP Jean-Pierre Enguent sells 35,000 shares

The sale comprised multiple transactions priced from $2.42 to $2.49 per share.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

SEALSQ Corp Vice President, R&DSS Jean-Pierre Enguent reported a sale of 35,000 ordinary shares on October 6, 2026, at a weighted average price of $2.4553 per share under a Rule 10b5-1 trading plan adopted October 13, 2025.

On October 5, 2026, he received an award of 50,000 employee stock options and exercised options covering 35,000 ordinary shares at $0.01 per share. The option exercise was also under the Rule 10b5-1 plan.

Insider Enguent Jean-Pierre
Role Vice President, R&DSS
Sold 35,000 shs ($86K)
Approx. gross sale proceeds $86K
Approx. exercise cost $350.00
Type Security Shares Price Value
Sale Ordinary Shares F1, F2 35,000 $2.4553 $86K
Grant/Award Employee Stock Option Plan (right to buy) 50,000 $0.00 $0.00
Exercise Employee Stock Option Plan (right to buy) F3 35,000 $0.00 $0.00
Exercise Ordinary Shares 35,000 $0.01 $350.00
Holdings After Transaction: Employee Stock Option Plan (right to buy) — 15,000 contracts (Direct); Ordinary Shares — 0 shares (Direct)
Footnotes (3)
  1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.42 to $2.49, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
  3. F3. The options exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025.
Ordinary shares sold 35,000 shares Sale on October 6, 2026
Weighted average sale price $2.4553 per share Sale on October 6, 2026
Sale price range $2.42 to $2.49 per share Multiple transactions on October 6, 2026
Employee stock options awarded 50,000 options Award on October 5, 2026
Options exercised 35,000 options Exercise on October 5, 2026
Exercise price $0.01 per share Options exercised on October 5, 2026
Option expiration date April 30, 2032 Reported employee stock options
Rule 10b5-1 trading plan regulatory
"pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Employee Stock Option Plan (right to buy) financial
"Employee Stock Option Plan (right to buy)"
exercise price financial
"conversion_or_exercise_price"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LAES shares did Jean-Pierre Enguent sell, and at what price?

Jean-Pierre Enguent sold 35,000 ordinary shares on October 6, 2026, at a weighted average price of $2.4553 per share. The shares were sold in multiple transactions at prices ranging from $2.42 to $2.49 under a Rule 10b5-1 trading plan adopted October 13, 2025.

How many LAES options did Jean-Pierre Enguent exercise, and at what price?

He exercised options covering 35,000 ordinary shares on October 5, 2026, at an exercise price of $0.01 per share. The exercise was under a Rule 10b5-1 trading plan adopted October 13, 2025.

When do Jean-Pierre Enguent's reported LAES options expire?

The reported employee stock options have an expiration date of April 30, 2032.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Enguent Jean-Pierre

(Last)(First)(Middle)
C/O SEALSQ CORP
AVENUE LOUIS-CASAI 58

(Street)
COINTRIN1216

(City)(State)(Zip)

SWITZERLAND

(Country)
2. Issuer Name and Ticker or Trading Symbol
SEALSQ Corp [ LAES ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Vice President, R&DSS
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares10/05/2026M35,000A$0.0135,000D
Ordinary Shares10/06/2026(1)S35,000D$2.4553(2)0D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option Plan (right to buy)$0.0110/05/2026A50,00010/05/202604/30/2032Ordinary Shares50,000$050,000D
Employee Stock Option Plan (right to buy)$0.0110/05/2026(3)M35,00010/05/202604/30/2032Ordinary Shares35,000$015,000D
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.42 to $2.49, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
3. The options exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025.
/s/ John O'Hara, Attorney-in-Fact10/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading